期刊文献+

肌炎抗体对特发性炎性肌病的诊断价值

The diagnostic value of myositis antibodies on idiopathic inflammatory myopathies
下载PDF
导出
摘要 目的探讨血清肌炎自身抗体对特发性炎性肌病(IIM)患者的诊断价值。方法采用线性免疫印迹法(LIA)检测225份血清标本肌炎自身抗体,筛选出阳性标本87例,观察不同疾病组肌炎抗体的阳性分布。对比分析各组单项和多项抗体阳性检出率。结果多发性肌炎(PM)组肌炎特异性自身抗体(MSAs)阳性率最高的为抗信号识别颗粒(SRP)抗体(22%);抗Mi-2抗体阳性的只检出1例,分布于皮肌炎(DM)组;抗合成酶抗体综合征(ASS)组MSAs阳性率最高的为抗Jo-1抗体(70%),与其它各组相比差异有统计学意义(P<0.05)。PM/DM组两个及以上抗体阳性的检出率分别为31.5%、35.7%,且均伴有抗Ro52抗体。ASS组两个及以上抗体同时阳性的检出率(70%)明显高于单项抗体检出率,差异具有统计学意义(P<0.05)。结论肌炎抗体的联合检测对IIM的诊断和临床分型具有重要价值。 Objective To investigate the diagnostic value of serum myositis autoantibodies on idiopathic inflammatory myopathy(IIM).Methods The myositis autoantibodies in 225 serum samples were detected by linear immunoblotting assay(LIA),in which,87 positive samples were screened out and the positive distribution of myositis antibodies in different disease groups was observed.The positive rates of single and multiple antibodies in each group were compared.Results The highest positive rate of myositis specific autoantibodies(MSAs)in the polymyositis(PM)group was the anti-signal recognition granule(SRP)antibody(22%);Only 1 case was positive for anti Mi-2 antibody,which was distributed in dermatomyositis group;The highest positive rate of MSAs in the anti-synthetase syndrome(ASS)group was anti-Jo-1 antibody(70%),and the difference was statistically significant compared with the other groups(P<0.05).The positive rates of two or more antibodies in PM/DM group were 31.5%and 35.7%,respectively,and were accompanied by anti-Ro52 antibody.The positive rate of two or more antibodies in ASS group was significantly higher than that in single antibody group(P<0.05).Conclusion Combined detection of myositis antibodies is of great value in the diagnosis and clinical typing of IIM.
作者 刘轩 李鸿斌 LIU Xuan;LI Hongbin(Laboratory of Rheumatology and Immunology,Affiliated Inner Mongolia Medical University, Inner Mongolia,Huhhot 010050,China)
出处 《国际检验医学杂志》 CAS 2018年第A02期61-64,共4页 International Journal of Laboratory Medicine
关键词 肌炎抗体 多发性肌炎 皮肌炎 诊断 myositis-antibodies PM DM diagnosis
  • 相关文献

参考文献4

二级参考文献40

  • 1谢瑶,卢昕,王国春.肌炎特异性抗体在多发性肌炎和皮肌炎中的意义[J].中华风湿病学杂志,2005,9(11):645-649. 被引量:11
  • 2Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev, 2010, 9: 449-453.
  • 3Targoff IN, Mamyrova G, Trieu EP, et al. A novel autoantibody to a 155 kD protein is associated with dennatomyositis. Arthritis Rheum, 2006, 54: 3682-3689.
  • 4Santheimer RD.Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine' myositis) as a distinctive subset within the idiopathic inflammatory dermatomyo- pathies spectrum of clinical illness. J Am Acad Dermatol, 2002, 46: 626-636.
  • 5Kaji K, Fujimoto M, Hasegawa M, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford), 2007, 46: 25-28.
  • 6Trallem-Araguas E, Labrador-Horrillo M, Selva-O'Callaghan A, et al. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore), 2010, 89: 47-52.
  • 7Chinoy H, Fertig N, Oddis CV, et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer- associated myositis. Ann Rheum Dis, 2007, 66: 1345-1349.
  • 8Gunawardena H, Wedderburn LR, North J, et al. Clinical associations of autoantibodies to a p155/140 kDa double protein in juvenile dermatomyositis. Rheumatology (Oxford), 2008, 47: 324-328.
  • 9Fujikawa K, Kawakami A, Kaji K et al. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti- 155/140-kDa polypeptides, anti-140-kDa polypeptides, and antiaminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol, 2009, 42 : 1-5.
  • 10Hoshino K, Muro Y, Sugiura K, et al. Anti-MDA5 and anti- TIF1-3, antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford), 2010, 49: 1726-1733.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部